about
Molecular carcinogenesis of canine mammary tumors: news from an old diseaseA novel triterpenoid isolated from the root bark of Ailanthus excelsa Roxb (Tree of Heaven), AECHL-1 as a potential anti-cancer agentNetwork based consensus gene signatures for biomarker discovery in breast cancerGenetically engineered ERα-positive breast cancer mouse models.Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.Pre-clinical validation of a selective anti-cancer stem cell therapy for Numb-deficient human breast cancers.Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United StatesIdentifying a highly-aggressive DCIS subgroup by studying intra-individual DCIS heterogeneity among invasive breast cancer patientsMotif-guided sparse decomposition of gene expression data for regulatory module identification.Deregulated estrogen receptor alpha and p53 heterozygosity collaborate in the development of mammary hyperplasia.Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinomaA Novel Unsupervised Algorithm for Biological Process-based Analysis on Cancer.Antitumor mechanisms of S-allyl mercaptocysteine for breast cancer therapy.Cysteine-rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cellsInferring cancer subnetwork markers using density-constrained biclusteringLoss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasisA functional p53 responsive polymorphism in KITLG, rs4590952, does not affect the risk of breast cancer.An aqueous extract of Fagonia cretica induces DNA damage, cell cycle arrest and apoptosis in breast cancer cells via FOXO3a and p53 expression.Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndromeMagnetite nanoparticles inhibit tumor growth and upregulate the expression of p53/p16 in Ehrlich solid carcinoma bearing miceIncreased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.Key signaling nodes in mammary gland development and cancer: β-catenin.Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancers.Ethylenediamine functionalized-single-walled nanotube (f-SWNT)-assisted in vitro delivery of the oncogene suppressor p53 gene to breast cancer MCF-7 cells.A novel radiation-induced p53 mutation is not implicated in radiation resistance via a dominant-negative effect.Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stressFibromatosis-like metaplastic carcinoma of the breast has a claudin-low immunohistochemical phenotype.Kernel machine approach to testing the significance of multiple genetic markers for risk prediction.Apoptosis in cancer: from pathogenesis to treatment.Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast.Integrative network-based approach identifies key genetic elements in breast invasive carcinoma.Molecular drivers of lobular carcinoma in situ.Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma.Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models.CCN5/WISP-2: A micromanager of breast cancer progressionBRCA1 Mutation: A Predictive Marker for Radiation Therapy?Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage.Glucocorticoid receptor activation inhibits p53-induced apoptosis of MCF10Amyc cells via induction of protein kinase Cε.p53, a target of estrogen receptor (ER) α, modulates DNA damage-induced growth suppression in ER-positive breast cancer cells.Deregulation of Internal Ribosome Entry Site-Mediated p53 Translation in Cancer Cells with Defective p53 Response to DNA Damage.
P2860
Q28300581-7A8183C6-E926-4148-B97B-B0DE4D0ABD7FQ28475423-40F4DAE6-4E5D-40E2-8317-7D0ADF5AD71EQ28477619-58949791-C2EF-4B1D-AD83-93A48CA5CBF2Q33578641-EDFC2453-187A-49AC-82F0-79DEFD938819Q33596695-FC00ED86-2509-4B18-9E65-11935678D191Q33626025-1DEBCB23-AA2B-4253-A466-05246F956597Q33748595-8F476BBB-F6E7-42DD-A357-908F0D055B7CQ33825677-4DE8472D-D3F0-466B-9AFF-7E73CCEC0B84Q33852615-874B9641-B2B5-46F1-9A9A-B882E47236A1Q33857846-D66FF444-56E3-42D2-B526-98B06891F871Q33867859-FBD1DBA4-422D-4F4D-90A3-350D64E8E9B0Q33875947-CAAF94FB-8AEA-429E-AFCB-BCD0683C273CQ34006770-95DCA1FC-79D0-45CD-8A04-9DC2B1809C74Q34054835-3A1299DC-7BF5-4F6F-A937-2D5CF7AE6A3AQ34110415-AD108D1D-4358-4325-98F0-A42C45BCD7BDQ34133391-C996005E-E20B-4199-872E-554BDE1CAE1BQ34178824-058F656A-49CE-409C-9EF2-41E078D235ABQ34326755-71F4A971-B05D-4A41-BCFD-2E68DF9CA1E0Q34335864-7457E07E-780F-4677-8C2F-E0A230E67A32Q34465935-5E82817B-2583-493C-A774-A3D95E91930AQ34489002-DC994416-ADFD-4950-94C9-62CF0BC77483Q34613461-EAA026CB-8476-4530-8B5F-DE9D6BF33125Q34664892-EA39C52B-DB90-4083-8152-BB87FF86CC10Q35071587-DED5CEF7-E214-4E91-AF69-DD67C5BCCBC0Q35099489-52B62248-FF70-4EC1-9EDB-84A01D5498B8Q35103873-17296654-D366-41D0-96F2-3A8FD1F6DE22Q35182598-CA71EAE0-2CD3-47AA-AEB7-492F3ED4E0D6Q35190688-FEBBE0D2-213F-4379-BDD3-6AD9EFBA5E0CQ35397889-602097B3-9C48-407D-92D1-A5D27916035AQ35586881-3C7C6AD0-1795-487F-8095-A683199DDEB4Q35651869-A515AFBA-8DEA-43B6-BE30-CDC9C94FF3E8Q35676504-0EB53048-F6B1-43AA-A9E1-48232817657FQ35846896-E7C7719A-F27B-45B4-95CB-A53442056F22Q35858051-48F55ADF-89E5-4BC0-9E39-3DFD40674599Q36010510-D8F1F7D6-8942-4562-8F78-94CD7AE84AE9Q36076772-EF72FF71-34BD-4146-8677-35C195183A7EQ36201008-032455E5-02FC-4719-85F0-81E10B96FB67Q36216063-71AD4D5E-7AC5-4B60-8E55-2C58384D9F9CQ36216301-D04D7618-7D9A-4CAB-B459-0E3F87C6D3D0Q36234278-65EF96F6-18B7-4D78-A0BB-DCDA17FB00AC
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The p53 pathway in breast cancer
@ast
The p53 pathway in breast cancer
@en
The p53 pathway in breast cancer
@nl
type
label
The p53 pathway in breast cancer
@ast
The p53 pathway in breast cancer
@en
The p53 pathway in breast cancer
@nl
prefLabel
The p53 pathway in breast cancer
@ast
The p53 pathway in breast cancer
@en
The p53 pathway in breast cancer
@nl
P2093
P2860
P921
P3181
P356
P1476
The p53 pathway in breast cancer
@en
P2093
Milena Gasco
Shukri Shami
P2860
P2888
P3181
P356
10.1186/BCR426
P407
P577
2002-02-12T00:00:00Z
P5875
P6179
1032275059